Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. | Nature | 2022 | 36198802 | PubTator, text mining | PubMed |
| A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma. | Front Immunol | 2022 | 36177018 | PubTator, text mining | PubMed |
| Exploring the role of mast cells in the progression of liver disease. | Front Physiol | 2022 | 36176778 | PubTator, text mining | PubMed |
| Liquid biopsies in primary and secondary bone cancers. | Cancer Drug Resist | 2022 | 36176757 | PubTator, text mining | PubMed |
| Emergence of Extensively Drug-Resistant ST170 Citrobacter portucalensis with Plasmids pK218-KPC, pK218-NDM, and pK218-SHV from a Tertiary Hospital, China. | Microbiol Spectr | 2022 | 36154205 | PubTator, text mining | PubMed |
| Fat Malabsorption and Ursodeoxycholic Acid Treatment in Children With Reduced Organic Solute Transporter-α (SLC51A) Expression. | JPGN Rep | 2022 | 36148443 | PubTator, text mining | PubMed |
| Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach. | Int J Biol Sci | 2022 | 36147475 | PubTator, text mining | PubMed |
| Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver Diseases. | Metabolites | 2022 | 36144184 | PubTator, text mining | PubMed |
| Successful Derivation of Hepatoblasts, Cholangiocytes and Hepatocytes from Simian Induced Pluripotent Stem Cells. | Int J Mol Sci | 2022 | 36142774 | PubTator, text mining | PubMed |
| In Vitro Rescue of the Bile Acid Transport Function of ABCB11 Variants by CFTR Potentiators. | Int J Mol Sci | 2022 | 36142670 | PubTator, text mining | PubMed |
| TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model. | Int J Mol Sci | 2022 | 36142143 | PubTator, text mining | PubMed |
| Vasor: Accurate prediction of variant effects for amino acid substitutions in multidrug resistance protein 3. | Hepatol Commun | 2022 | 36111625 | PubTator, text mining | PubMed |
| Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis. | Front Pharmacol | 2022 | 36110537 | PubTator, text mining | PubMed |
| Naturally Acquired Kelch13 Mutations in Plasmodium falciparum Strains Modulate In Vitro Ring-Stage Artemisinin-Based Drug Tolerance and Parasite Survival in Response to Hyperoxia. | Microbiol Spectr | 2022 | 36094220 | PubTator, text mining | PubMed |
| Case Report: Three novel pathogenic ABCC2 mutations identified in two patients with Dubin-Johnson syndrome. | Front Genet | 2022 | 36092886 | PubTator, text mining | PubMed |
| Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview. | Front Pharmacol | 2022 | 36091785 | PubTator, text mining | PubMed |
| Reduced peroxisome proliferator-activated receptor-α and bile acid nuclear receptor NR1H4/FXR may affect the hepatic immune microenvironment of biliary atresia. | Front Immunol | 2022 | 36090996 | PubTator, text mining | PubMed |
| Identifying interpretable gene-biomarker associations with functionally informed kernel-based tests in 190,000 exomes. | Nat Commun | 2022 | 36088354 | PubTator, text mining | PubMed |
| Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities. | Cells | 2022 | 36078127 | PubTator, text mining | PubMed |
| Guidelines for the Management of Cholestatic Liver Diseases (2021). | J Clin Transl Hepatol | 2022 | 36062287 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=24